Pure Global
NCT05901415

Modified LPB and SPB vs Classical LPB and SPB

Combined Anterior Lumbar Plexus and Lateral Sacral Plexus Block in a Semi-supine Position for Hip Fracture Surgery in Elderly Patients: A Randomized Controlled Trial
Peking Union Medical College Hospital·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anesthesia, Local
Drug/Device/Intervention
Combined anterior lumbar plexus and lateral sacral plexus block in a semi-supine position
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Peking Union Medical College Hospital
Timeline & enrollment
Phase
N/A
Start date
Jul 07, 2023
End date
Jun 10, 2025
Enrollment
30 participants
Primary outcome

Visual Analogue Scale Score

Summary

The timing of surgery for hip fractures is crucial for elderly patients. The mortality rate
 for elderly patients after hip fracture is high, and anesthetic decisions significantly
 affect the patient's outcome. Regional anesthesia has been shown to have better outcomes than
 general anesthesia. We proposed a newly developed modified position for the ultrasound-guided
 combined anterior lumbar and lateral sacral plexus block technique that offers benefits,
 including minimizing interference with circulation and anesthesia, avoiding position change
 and pain, and providing effective postoperative analgesia.

ICD-10 classifications
Local anaestheticsAnaesthetic, unspecifiedOther and unspecified general anaestheticsPoisoning: Local anaestheticsParenteral anaesthetics
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05901415
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05901415 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently Not yet recruiting. The study focuses on Anesthesia, Local. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.